Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
Royalty Pharma (NASDAQ:RPRX) has announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference. The company will engage in a fireside chat on Tuesday, September 9, 2025, at 3:20 p.m. ET. Investors can access the webcast through Royalty Pharma's "Events" page on their investor relations website, where it will remain archived for at least thirty days.
Royalty Pharma (NASDAQ:RPRX) ha confermato la sua partecipazione alla 23陋 Morgan Stanley Annual Global Healthcare Conference. L'azienda terr脿 una fireside chat marted矛 9 settembre 2025 alle 15:20 ET. Gli investitori potranno seguire la webcasting dalla pagina 芦Eventi禄 del sito investor relations di Royalty Pharma, dove sar脿 archiviato per almeno trenta giorni.
Royalty Pharma (NASDAQ:RPRX) ha anunciado su participaci贸n en la 23.陋 Morgan Stanley Annual Global Healthcare Conference. La compa帽铆a participar谩 en una charla informal (fireside chat) el martes 9 de septiembre de 2025 a las 3:20 p.m. ET. Los inversores podr谩n acceder a la retransmisi贸n desde la p谩gina 芦Events禄 del sitio de relaciones con inversores de Royalty Pharma, donde permanecer谩 archivada durante al menos treinta d铆as.
Royalty Pharma (NASDAQ:RPRX)電� Morgan Stanley 鞝�23須� 鞐半 旮�搿滊矊 項姢旒�鞏� 旖橅嵓霟办姢鞐� 彀胳棳頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 2025雲� 9鞗� 9鞚� 頇旍殧鞚� 霃欕秬 響滌鞁� 旮办 鞓ろ泟 3鞁� 20攵�鞐� 韺岇澊鞏挫偓鞚措摐 毂勴寘鞚� 歆勴枆頃╇媹雼�. 韴瀽鞛愲摛鞚� Royalty Pharma 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼鞚� 鈥淓vents鈥� 韼橃澊歆�鞐愳劀 鞗轨簮鞀ろ姼毳� 鞁滌箔頃� 靾� 鞛堨溂氅�, 頃措嫻 鞓侅儊鞚� 斓滌唽 30鞚缄皠 氤搓磤霅╇媹雼�.
Royalty Pharma (NASDAQ:RPRX) a annonc茅 sa participation 脿 la 23e Morgan Stanley Annual Global Healthcare Conference. La soci茅t茅 tiendra un fireside chat le mardi 9 septembre 2025 脿 15h20 ET. Les investisseurs pourront acc茅der au webcast via la page 芦 Events 禄 du site relations investisseurs de Royalty Pharma, o霉 il restera archiv茅 pendant au moins trente jours.
Royalty Pharma (NASDAQ:RPRX) hat seine Teilnahme an der 23. Morgan Stanley Annual Global Healthcare Conference angek眉ndigt. Das Unternehmen wird an einem Fireside Chat am Dienstag, den 9. September 2025, um 15:20 Uhr ET teilnehmen. Investoren k枚nnen das Webcast 眉ber die 鈥濫vents鈥�-Seite auf der Investor-Relations-Website von Royalty Pharma aufrufen; die Aufzeichnung wird dort mindestens drei脽ig Tage verf眉gbar sein.
- None.
- None.
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025 at 3:20 p.m. ET.
The webcast will be accessible from Royalty Pharma鈥檚 鈥淓vents鈥� page at . The webcast will also be archived for a minimum of thirty days.
About Royalty Pharma
Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap="/articles/market-capitalization-explained" title="Read: What Is Market Capitalization and How It Is Calculated" class="article-link" rel="noopener">mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry鈥檚 leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly 鈥� directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma鈥檚 current portfolio includes royalties on more than 35 commercial products, including Vertex鈥檚 Trikafta, GSK鈥檚 Trelegy, Roche鈥檚 Evrysdi, Johnson & Johnson鈥檚 Tremfya, Biogen鈥檚 Tysabri and Spinraza, Servier鈥檚 Voranigo, AbbVie and Johnson & Johnson鈥檚 Imbruvica, Astellas and Pfizer鈥檚 Xtandi, Pfizer鈥檚 Nurtec ODT, and Gilead鈥檚 Trodelvy, and 17 development-stage product candidates. For more information, visit .听听听
Royalty Pharma Investor Relations and Communications
+1 (212) 883-6637
FAQ
When is Royalty Pharma (RPRX) presenting at the Morgan Stanley Healthcare Conference 2025?
How can investors watch Royalty Pharma's Morgan Stanley conference presentation?
How long will Royalty Pharma's Morgan Stanley conference presentation be available online?
What type of presentation will RPRX give at the Morgan Stanley Healthcare Conference?
